Doxorubicin, Paclitaxel, and Carboplatin in Treating Patients With Primary Stage III, Stage IV, or Recurrent Endometrial Cancer

NCT00006377 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

OTHER

Sponsor class

Conditions

Endometrial Cancer

Interventions

DRUG: carboplatin
DRUG: doxorubicin hydrochloride
DRUG: paclitaxel

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]